Whalesbook
Record Foreign Investor Sell-off Amid Market Pressures
India's stock market is experiencing high volatility due to major foreign institutional investor (FII) outflows. In March 2026 alone, FIIs sold approximately ₹1.14 lakh crore of Indian shares, setting a new monthly record. This brings the total divestment this year to over ₹1.27 lakh crore. The aggressive selling is driven by rising geopolitical tensions in the Middle East, particularly the US-Iran conflict, which has sent crude oil prices sharply higher. The Indian Rupee has weakened to record lows around 94.86 against the US Dollar. This currency drop worsens foreign investor worries about inflation and lower profits when sending money home. This cautious mood is pushing global money toward safer assets, away from emerging markets seen as riskier.
Nifty Index Faces Resistance, Market Sentiment Weak
The Nifty 50 index mirrors this widespread caution, struggling to hold gains and facing strong resistance around the 23,150–23,200 level. The index has immediate support at 22,650–22,600. A break below this zone could see it fall further to 22,400 and 22,200. The market tends to see brief rallies followed by sharp drops, showing weak investor confidence. This pattern reinforces advice from market watchers to 'sell on rise,' meaning short-term gains might not last long and are unlikely to signal a lasting trend reversal.
Select Stocks Show Strength Despite Broad Declines
Despite the widespread bearish sentiment and large FII withdrawals, a few stocks are showing notable technical strength. Emcure Pharmaceuticals, trading around ₹1,652.7, is in an uptrend, holding above ₹1,580. Its P/E ratio is about 34.6x, slightly higher than the Indian Pharmaceuticals industry average of 25.8x but within its peer range. HEG and Graphite India, which manufacture graphite electrodes, are showing positive movement above the middle of their Bollinger Bands. HEG's P/E is around 38.46x, and Graphite India's is near 36.0x, with both having market values around ₹12,500 crore.
Anthem Biosciences, a mid-cap company valued near ₹38,000 crore, shows strong momentum after breaking out of a trading range, backed by rising volumes and improved technical signals. However, its P/E ratio of about 76.0x is quite high compared to market averages, suggesting a premium valuation that needs careful watching. Lupin, a major pharmaceutical firm worth over ₹1 lakh crore, has a strong technical setup. Analysts project price targets around ₹2,460, even though its future earnings are expected to drop. Its current P/E of about 23x looks attractive compared to peers and the industry average. Oracle Financial Services Software (OFSS), a large IT solutions provider, is consolidating but has a solid P/E of about 23.5x, trading below its estimated fair value and peers. Supreme Petrochem, valued at around ₹14,200 crore, has also broken out with volume support, though its P/E of over 50x is high for the chemicals sector.
Risks Remain: High Valuations and Market Fragility
The biggest risk for India's market is continued foreign capital leaving, fueled by ongoing geopolitical worries and a falling rupee. The large sell-off suggests investors don't expect a quick recovery, which could further weaken the rupee and push down stock prices. For stocks showing resilience, especially Anthem Biosciences and Supreme Petrochem, their high P/E ratios pose a significant risk. A deeper market correction or prolonged economic stress could cause these high-priced stocks to fall. Also, Lupin's expected drop in earnings per share, despite revenue growth, suggests possible cost pressures or business issues that could limit its gains. The market's reliance on domestic institutional investors (DIIs) to support prices shows an underlying weakness that could appear if DII buying slows.
Outlook: Cautious Hopes for Some Stocks
While overall market sentiment is negative due to economic and geopolitical issues, some companies are showing technical strength. For Lupin, analysts predict potential price targets around ₹2,460, suggesting some confidence in its short-term performance despite expected lower earnings. For the wider market, a stronger dollar easing and fewer geopolitical conflicts are needed to attract steady foreign investment back. Until then, investors might find opportunities in companies with strong individual strengths and technical breakouts, while staying alert to wider market risks and the high prices of some successful stocks.